Humana HUM
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Humana (HUM) Core Market Data and Business Metrics
Latest Closing Price
$265.8Price-Earnings Ratio
26.63Total Outstanding Shares
120.69 Million SharesDividend
$0.89 Per Share QuarterlySIC Description
Hospital & Medical Service PlansPrimary Exchange
New York Stock ExchangeHeadquarters
500 W Main St, Louisville, KY, 40202
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 1,395,356 Shares | 2.39 | 3/14/2025 | 3,332,285 Shares |
| 1,692,881 Shares | 2.16 | 2/28/2025 | 3,660,419 Shares |
| 2,108,120 Shares | 2.04 | 2/14/2025 | 4,296,359 Shares |
| 1,691,689 Shares | 2.71 | 1/31/2025 | 4,582,728 Shares |
| 1,311,774 Shares | 3.95 | 1/15/2025 | 5,175,421 Shares |
| 2,217,463 Shares | 2.52 | 12/31/2024 | 5,581,342 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities, Continuing | $-2.49 Billion |
| Net Cash Flow, Continuing | $-2.47 Billion |
| Net Cash Flow From Investing Activities, Continuing | $-2.95 Billion |
| Net Cash Flow From Operating Activities | $2.97 Billion |
| Net Cash Flow From Operating Activities, Continuing | $2.97 Billion |
| Net Cash Flow From Investing Activities | $-2.95 Billion |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income Tax Expense/Benefit, Current | $605 Million |
| Benefits Costs and Expenses | $115.20 Billion |
| Income Tax Expense/Benefit | $413 Million |
| Income/Loss From Equity Method Investments | $-94 Million |
| Preferred Stock Dividends And Other Adjustments | $0 |
| Income Tax Expense/Benefit, Deferred | $-192 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Other Comprehensive Income/Loss | $-68 Million |
| Other Comprehensive Income/Loss Attributable To Parent | $-68 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss | $1.14 Billion |
| Comprehensive Income/Loss Attributable To Parent | $1.14 Billion |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Current Assets | $29.82 Billion |
| Liabilities And Equity | $46.48 Billion |
| Equity Attributable To Parent | $16.38 Billion |
| Equity Attributable To Noncontrolling Interest | $70 Million |
| Other Non-current Assets | $12.69 Billion |
| Assets | $46.48 Billion |
Historical Dividends
Current dividend: $0.89 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 20, 2025 | Apr 25, 2025 | Mar 28, 2025 | $0.885 | Quarterly |
| Oct 24, 2024 | Jan 31, 2025 | Dec 31, 2024 | $0.885 | Quarterly |
| Aug 15, 2024 | Oct 25, 2024 | Sep 30, 2024 | $0.885 | Quarterly |
| Apr 18, 2024 | Jul 26, 2024 | Jun 28, 2024 | $0.885 | Quarterly |
| Feb 15, 2024 | Apr 26, 2024 | Mar 29, 2024 | $0.885 | Quarterly |
| Oct 31, 2023 | Jan 26, 2024 | Dec 29, 2023 | $0.885 | Quarterly |